Cargando…
Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses
BACKGROUND: Chronic Chagas disease presents different clinical manifestations ranging from asymptomatic (namely indeterminate) to severe cardiac and/or digestive. Previous results have shown that the immune response plays an important role, although no all mechanisms are understood. Immunoregulatory...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852404/ https://www.ncbi.nlm.nih.gov/pubmed/27138039 http://dx.doi.org/10.1186/s12879-016-1523-1 |
_version_ | 1782429932860735488 |
---|---|
author | Chaves, Ana Thereza de Assis Silva Gomes Estanislau, Juliana Fiuza, Jacqueline Araújo Carvalho, Andréa Teixeira Ferreira, Karine Silvestre Fares, Rafaelle Christine Gomes Guimarães, Pedro Henrique Gazzinelli de Souza Fagundes, Elaine Maria Morato, Maria José Fujiwara, Ricardo Toshio da Costa Rocha, Manoel Otávio Correa-Oliveira, Rodrigo |
author_facet | Chaves, Ana Thereza de Assis Silva Gomes Estanislau, Juliana Fiuza, Jacqueline Araújo Carvalho, Andréa Teixeira Ferreira, Karine Silvestre Fares, Rafaelle Christine Gomes Guimarães, Pedro Henrique Gazzinelli de Souza Fagundes, Elaine Maria Morato, Maria José Fujiwara, Ricardo Toshio da Costa Rocha, Manoel Otávio Correa-Oliveira, Rodrigo |
author_sort | Chaves, Ana Thereza |
collection | PubMed |
description | BACKGROUND: Chronic Chagas disease presents different clinical manifestations ranging from asymptomatic (namely indeterminate) to severe cardiac and/or digestive. Previous results have shown that the immune response plays an important role, although no all mechanisms are understood. Immunoregulatory mechanisms such as apoptosis are important for the control of Chagas disease, possibly affecting the morbidity in chronic clinical forms. Apoptosis has been suggested to be an important mechanism of cellular response during T. cruzi infection. We aimed to further understand the putative role of apoptosis in Chagas disease and its relation to the clinical forms of the disease. METHODS: Apoptosis of lymphocytes, under antigenic stimuli (soluble T. cruzi antigens – TcAg) where compared to that of non-stimulated cells. Apoptosis was evaluated using the expression of annexin and caspase 3(+) by T cells and the percentage of cells positive evaluated by flow cytometry. In addition activation and T cell markers were used for the identification of TCD4(+) and TCD8(+) subpopulations. The presence of intracellular and plasma cytokines were also evaluated. Analysis of the activation status of the peripheral blood cells showed that patients with Chagas disease presented higher levels of activation determined by the expression of activation markers, after TcAg stimulation. PCR array were used to evaluate the contribution of this mechanism in specific cell populations from patients with different clinical forms of human Chagas disease. RESULTS: Our results showed a reduced proliferative response associated a high expression of T CD4(+)CD62L(−) cells in CARD patients when compared with IND group and NI individuals. We also observed that both groups of patients presented a significant increase of CD4(+) and CD8(+) T cell subsets in undergoing apoptosis after in vitro stimulation with T. cruzi antigens. In CARD patients, both CD4(+) and CD8(+) T cells expressing TNF-α were highly susceptible to undergo apoptosis after in vitro stimulation. Interestingly, the in vitro TcAg stimulation increased considerably the expression of cell death TNF/TNFR superfamily and Caspase family receptors genes in CARD patients. CONCLUSIONS: Taken together, our results suggest that apoptosis may be an important mechanism for the control of morbidity in T. cruzi infection by modulating the expression of apoptosis genes, the cytokine environment and/or killing of effector cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1523-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4852404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48524042016-05-03 Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses Chaves, Ana Thereza de Assis Silva Gomes Estanislau, Juliana Fiuza, Jacqueline Araújo Carvalho, Andréa Teixeira Ferreira, Karine Silvestre Fares, Rafaelle Christine Gomes Guimarães, Pedro Henrique Gazzinelli de Souza Fagundes, Elaine Maria Morato, Maria José Fujiwara, Ricardo Toshio da Costa Rocha, Manoel Otávio Correa-Oliveira, Rodrigo BMC Infect Dis Research Article BACKGROUND: Chronic Chagas disease presents different clinical manifestations ranging from asymptomatic (namely indeterminate) to severe cardiac and/or digestive. Previous results have shown that the immune response plays an important role, although no all mechanisms are understood. Immunoregulatory mechanisms such as apoptosis are important for the control of Chagas disease, possibly affecting the morbidity in chronic clinical forms. Apoptosis has been suggested to be an important mechanism of cellular response during T. cruzi infection. We aimed to further understand the putative role of apoptosis in Chagas disease and its relation to the clinical forms of the disease. METHODS: Apoptosis of lymphocytes, under antigenic stimuli (soluble T. cruzi antigens – TcAg) where compared to that of non-stimulated cells. Apoptosis was evaluated using the expression of annexin and caspase 3(+) by T cells and the percentage of cells positive evaluated by flow cytometry. In addition activation and T cell markers were used for the identification of TCD4(+) and TCD8(+) subpopulations. The presence of intracellular and plasma cytokines were also evaluated. Analysis of the activation status of the peripheral blood cells showed that patients with Chagas disease presented higher levels of activation determined by the expression of activation markers, after TcAg stimulation. PCR array were used to evaluate the contribution of this mechanism in specific cell populations from patients with different clinical forms of human Chagas disease. RESULTS: Our results showed a reduced proliferative response associated a high expression of T CD4(+)CD62L(−) cells in CARD patients when compared with IND group and NI individuals. We also observed that both groups of patients presented a significant increase of CD4(+) and CD8(+) T cell subsets in undergoing apoptosis after in vitro stimulation with T. cruzi antigens. In CARD patients, both CD4(+) and CD8(+) T cells expressing TNF-α were highly susceptible to undergo apoptosis after in vitro stimulation. Interestingly, the in vitro TcAg stimulation increased considerably the expression of cell death TNF/TNFR superfamily and Caspase family receptors genes in CARD patients. CONCLUSIONS: Taken together, our results suggest that apoptosis may be an important mechanism for the control of morbidity in T. cruzi infection by modulating the expression of apoptosis genes, the cytokine environment and/or killing of effector cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1523-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-30 /pmc/articles/PMC4852404/ /pubmed/27138039 http://dx.doi.org/10.1186/s12879-016-1523-1 Text en © Chaves et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Chaves, Ana Thereza de Assis Silva Gomes Estanislau, Juliana Fiuza, Jacqueline Araújo Carvalho, Andréa Teixeira Ferreira, Karine Silvestre Fares, Rafaelle Christine Gomes Guimarães, Pedro Henrique Gazzinelli de Souza Fagundes, Elaine Maria Morato, Maria José Fujiwara, Ricardo Toshio da Costa Rocha, Manoel Otávio Correa-Oliveira, Rodrigo Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses |
title | Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses |
title_full | Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses |
title_fullStr | Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses |
title_full_unstemmed | Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses |
title_short | Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses |
title_sort | immunoregulatory mechanisms in chagas disease: modulation of apoptosis in t-cell mediated immune responses |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852404/ https://www.ncbi.nlm.nih.gov/pubmed/27138039 http://dx.doi.org/10.1186/s12879-016-1523-1 |
work_keys_str_mv | AT chavesanathereza immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT deassissilvagomesestanislaujuliana immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT fiuzajacquelinearaujo immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT carvalhoandreateixeira immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT ferreirakarinesilvestre immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT faresrafaellechristinegomes immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT guimaraespedrohenriquegazzinelli immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT desouzafagundeselainemaria immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT moratomariajose immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT fujiwararicardotoshio immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT dacostarochamanoelotavio immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses AT correaoliveirarodrigo immunoregulatorymechanismsinchagasdiseasemodulationofapoptosisintcellmediatedimmuneresponses |